Search

Search Constraints

You searched for: Author/Creator Pelizzari, G

Search Results

2. 236PClinical decision making and multidisciplinary team meetings (MDMs) in early breast cancer. Is the agreement between planned and applied therapeutic program?. (1st October 2019)

3. 302PA risk score integrating lymphocytes ratios (LRs) and lactate dehydrogenase (LDH) levels to predict prognosis in metastatic breast cancer (MBC) patients. (23rd October 2018)

4. 540PMonocyte-to-lymphocyte ratio in metastatic colorectal cancer: Prognostic role evaluation and cut-off definition. (23rd October 2018)

5. 593PThe SENECA study: Prognostic role of serum biomarkers in elderly metastatic colorectal cancer patients. (23rd October 2018)

6. 594PDeterminants of oncologist's choice in offering drug holidays during first line therapy for patients with metastatic colorectal cancer. (23rd October 2018)

7. 7PMonocyte-to-lymphocye ratio (MLR) and LDH level in metastatic colorectal cancer (mCRC) patients (pts). (17th December 2018)

8. C18Strategy of monitoring metastatic breast cancer (M-MBC) in clinical practice: more or less intensive?. (6th November 2017)

9. E25First-line platinum-based chemotherapy in elderly patients with NSCLC: determinants of therapeutic choice and outcome. (6th November 2017)

10. EP795 Searching for the best maintenance therapy in platinum-sensitive recurrent ovarian cancer: bevacizumab or PARP-inhibitors? A network meta-analysis. (1st November 2019)